The IDIBAPS Management Committee has approved the leadership transition of the research group “Hepatic Hemodynamics and Portal Hypertension.” Virginia Hernández‑Gea is the new group leader, replacing Juan Carlos Garcia-Pagán, who has chosen to step down from the leadership role and will remain in the group as an R3A researcher. The group has also updated its name and will now be known as “Liver disease and vascular system (LiVas).”
Virginia Hernández‑Gea holds a degree in Medicine from the Miguel Hernández University of Elche and is a specialist in gastroenterology and hepatology, having completed her residency at Hospital de Sant Pau in Barcelona. She obtained her PhD from the Autonomous University of Barcelona and carried out postdoctoral stays at the Mount Sinai Medical School in New York and at IDIBAPS. She is currently a consultant in the Hepatology Department at Clínic Barcelona and an associate professor at the University of Barcelona. Her research focuses on hepatic vascular diseases and portal hypertension, with an extensive scientific output and leadership in several national and international competitive projects. She also actively participates in international scientific societies and contributes to the editorial work of specialized hepatology journals.
